Medication

Why does menopause status matter for breast cancer medicines?

Some people receiving endocrine therapy for breast cancer take tamoxifen, others an aromatase inhibitor, and some also need ovarian suppression. These treatments act at different points, and menopause status affects the plan. Periods stopping after chemotherapy alone does not establish that ovarian function has permanently stopped.

SinoCareHub Content Team·November 2, 2026·4 min

Start with the pathology report

Menopause status affects treatment because the main source of oestrogen differs before and after menopause. While the ovaries are still functioning, some medicines need to be combined with ovarian suppression to achieve their treatment purpose.[1] Questions about periods and previous treatment help the doctor understand the conditions in which the medicines will work.

This article concerns adjuvant endocrine therapy after surgery in adult women with early-stage, hormone receptor-positive breast cancer. ER and PR on the pathology report mean oestrogen receptor and progesterone receptor. Endocrine therapy inhibits the tumour by reducing hormone production or blocking hormones’ effects on cancer cells; one purpose of treatment after surgery is to reduce recurrence risk.[1]

Endocrine therapy is also different from hormone replacement for menopause. The purposes differ, so hot flushes or night sweats are not a reason to buy hormone supplements on your own.[1,2]

Two types of tablets, different roles

Tamoxifen acts mainly at oestrogen receptors in breast cells, blocking stimulation from oestrogen. It can be used before or after menopause.[1]

Letrozole, anastrozole and exemestane are aromatase inhibitors. They inhibit an enzyme needed to make oestrogen and are used mainly after menopause. While the ovaries are active, these medicines alone cannot adequately suppress the ovarian source of oestrogen. Premenopausal patients receiving this type of treatment therefore need appropriate ovarian suppression.[1]

Ovarian suppression is a separate part of treatment and can be achieved with medicines, among other methods.[3] This can explain why injections are sometimes needed alongside tablets: the treatments control different parts of the process. Price, how new a medicine is, or another patient’s prescription cannot by themselves determine how your own plan compares.

No periods after chemotherapy does not mean permanent menopause

Chemotherapy can stop periods, but ovarian function may remain or recover later. The China Anti-Cancer Association’s 2024 consensus specifically states that, for patients who were premenopausal before chemotherapy, the absence of periods afterwards does not establish menopause.[3]

This is why information about periods before treatment is worth retaining for a breast specialist consultation in China. Whether periods are happening now is only part of the picture; previous chemotherapy, endocrine medicines or ovarian suppression also affect the assessment.[3]

Do not use an age, a number of months without periods or a single hormone test to decide on changing medicine or cancelling injections yourself. Your treating team assesses ovarian function and the medication plan in the context of your treatment. The team also decides which tests are needed.

Follow-up checks more than recurrence

Follow-up during endocrine therapy also manages changes caused by treatment. A Chinese management guideline published in 2025 separately discusses endometrial problems associated with tamoxifen, and muscle or joint symptoms and reduced bone density associated with aromatase inhibitors.[2] Gynaecological examinations and bone-density tests therefore assess different things and cannot replace one another.

Report abnormal vaginal bleeding promptly to the treating team and seek gynaecological care; bone health needs assessment in relation to your treatment plan and personal risks.[2] Side effects deserve attention, but decisions about continuing, adjusting or stopping medicine must come from your treating doctor. Follow their instructions.

For further assessment in China, use the medical-records preparation guide to organise pathology reports, treatment records, current medicines and available test results. Keep the ER and PR results and information about periods before and after treatment in particular. If English communication support is needed, SinoCareHub’s medical interpreting escort can help record the doctor’s explanations of the medicines’ roles, the purposes of follow-up tests and the next arrangements. It does not choose medicines for the doctor.